CHEMOTHERAPY-SURGERY INTERVAL EFFECTS ON TUMOR NECROSIS AND OUTCOME IN CHILDREN AND YOUNG ADULTS WITH OSTEOSARCOMA
Rachel B. Mersfelder B.A. 1, Cara Lwin B.S.2, Shahid Malik M.D. 3, Thomas C. Badgett M.D., Ph. D. 4, Stephen W. Chenard MSc.5, Akhil Rekulapelli B.S. 5, Bryan S. Blette Ph.D. 2, Joshua M. Lawrenz M.D., MSc.5, Scott C. Borinstein M.D., Ph.D. *1
1 Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee
2 Department of Biostatistics, Vanderbilt University, Nashville, Tennessee
3 Division of Pediatric Hematology-Oncology, Department of Pediatrics, East Tennessee Children’s Hospital, Knoxville, Tennessee
4 Division of Pediatric Hematology-Oncology, Kentucky Children’s Hospital, Louisville, Kentucky
5 Department of Orthopedic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
* Corresponding author
Scott C. Borinstein M.D., Ph.D.
Preston Research Building
2220 Pierce Avenue, Room / Suite 390
Nashville, TN 37232
(615) 936-1762
scott.c.borinstein@vumc.org
Word count
Abstract: 250 words
Main Text: 2496 words
5 figures, 1 table, 1 supplemental table
Running Title: Delays in local control in patients with osteosarcoma
Keywords: Osteosarcoma, outcomes, chemotherapy, pediatrics, cancer
Abbreviations